U.S. Treasury Secretary Yellen: 3.8% Inflation is Just a Short-Term Disruption
On June 4, U.S. Treasury Secretary Janet Yellen continued to express the same assessment regarding recent inflation trends in Congress and public appearances: the current price increases are primarily due to short-term shocks rather than structural issues. During a Senate Finance Committee hearing, she stated clearly, "Aside from inflation—I believe this will be a short-term disruption—other economic data is very strong." This statement continues her previous definitions regarding the nature of rising prices. Data from April showed that due to heightened energy costs stemming from tensions in the Strait of Hormuz, the overall Consumer Price Index (CPI) in the U.S. rose by 3.8% year-on-year, marking the largest increase in 2023. Yellen attributed this change to supply shocks caused by the conflict in Iran and repeatedly emphasized its one-time nature. In May, she explained, "I firmly believe that nothing is more temporary than supply shocks." In a White House cabinet meeting, she provided the same assessment, believing that as the conflict ends, energy prices will decline, stating, "When all of this is over, oil prices will be below pre-conflict levels," while also noting that natural gas prices have already begun to decrease. Similar views are reflected in her interpretation of financial markets. Yellen previously mentioned that the rise in global bond yields reflects "what I believe to be fleeting short-term inflationary fluctuations"; in another cabinet meeting, she emphasized, "I believe the rise in prices is temporary."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Kepler Weber executives trim stake by R$ 24,461.40 via on-market sales
Kepler Weber disclosed two cash equity sales by management totaling 3,788 shares for R$ 24,461.40 at an average R$ 6.45674. Transactions were executed via XP, with sales on day 1 at R$ 6.55 and day 16 at R$ 6.41. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kepler Weber SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
BUZZ - Universal Display shares fall after Citi downgraded rating
On October 8, shares of OLED materials company Universal Display (OLED.O) fell by 4.5% in pre-market trading to $73.8. Citigroup downgraded Universal Display from “Neutral” to “Sell” and lowered its price target from $85 to $71. The new target price implies about an 8% downside from the previous closing price. The brokerage pointed out the continued weakness in the smartphone market and delays in the adoption of blue OLED technology. Citigroup also noted that high memory costs and weak demand for mid- and low-end smartphones may continue to drag down sales of OLED materials. Out of 10 brokerages, seven rate the stock as “Buy” or higher, and three rate it as “Hold.” The median price target is $117.5. As of the previous trading day's close, the stock had fallen a cumulative 33.88% so far this year.
ICON schedules third-quarter earnings conference call
ICON will report third-quarter 2026 results on Tuesday, Oct. 27, 2026, following the market close. Management will discuss the results on an earnings call, webcast Wednesday, Oct. 28, 2026, at 8:00 a.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICON plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202610080800BIZWIRE_USPR_____20261008_BW018649) on October 08, 2026, and is solely responsible for the information contained therein.
BUZZ-Atrium Therapeutics shares surge after completing $50 million equity financing
On October 8, shares of heart disease drug developer Atrium Therapeutics (RNA.O) rose 11.3% to $8.83 in pre-market trading on Thursday after the company successfully raised $50 million. The biopharmaceutical company announced it has agreed to sell about 6.3 million shares and pre-funded warrants to institutional investors through a private placement at $7.93 per share. RNA’s shares closed down 0.8% at $7.93 on Wednesday and have fallen roughly 44% in the past month. The company plans to use the net proceeds for the development of its two main product candidates, other research projects, among other uses. Atrium expects that the funds raised, together with existing cash and investments, will be sufficient to support its operations through 2028. Leerink acted as the lead placement agent for this offering, with Cantor Fitzgerald, Barclays, and Wells Fargo participating as well. Based in San Diego, California, Atrium has signed collaboration agreements with Bristol Myers Squibb (BMY.N) and Eli Lilly (LLY.N), and has about 17.1 million shares outstanding. Atrium began public trading on February 27 (link), following a spinoff from Avidity Biosciences (link), which was subsequently acquired by Swiss pharmaceutical company Novartis (NOVN.S).
Crypto prices
More
